Sorry @bedger but Mesoblast are not running the trials, that is being done by the Icahn School of Medicine. And that adds even more credibility to the study results when they do come out.
From https://clinicaltrials.gov/ct2/show/study/NCT04371393?term=mesoblast&draw=2
- Forums
- ASX - By Stock
- MSB
- Countdown to Interim Analysis
Countdown to Interim Analysis, page-91
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
0.015(1.03%) |
Mkt cap ! $1.684B |
Open | High | Low | Value | Volume |
$1.46 | $1.49 | $1.44 | $3.209M | 2.199M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 11614 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 19263 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 11625 | 1.460 |
10 | 53923 | 1.455 |
10 | 107886 | 1.450 |
6 | 59155 | 1.445 |
8 | 143389 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 19263 | 10 |
1.470 | 65295 | 9 |
1.475 | 49594 | 7 |
1.480 | 150254 | 15 |
1.485 | 108529 | 10 |
Last trade - 15.47pm 21/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online